Valuation Cuorips Inc.

Stocks

Delayed Japan Exchange 00:41:42 2026-10-15 EDT			5-day change	1st Jan Change
6,280.00 ^JPY	-2.18%		+3.80%	+4.15%

09-27	Cuorips Inc. announced that it has received ¥2.9999677 billion in funding from JIC Venture Growth Investments Co., Ltd.	CI
09-11	Cuorips Inc. announced that it expects to receive ¥2.9999677 billion in funding from JIC Venture Growth Investments Co., Ltd.	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2024	2025	2026
Market Cap ¹	29,126	67,173	57,885
Change	-	130.63%	-13.83%
Enterprise Value (EV) ¹	23,544	62,380	53,986
Change	-	164.96%	-13.46%
P/E	-43x	-103x	-56.3x
PBR	4.91x	12.2x	12.2x
PEG	-	16.48x	-1x
Capitalization / Revenue	1,266x	384x	273x
EV / Revenue	1,024x	356x	255x
EV / EBITDA	-45.5x	-121x	-54.1x
EV / EBIT	-40x	-106x	-49.9x
EV / FCF	-	-	-
FCF Yield	-	-	-
Dividend per Share ²	-	-	-
Rate of return	-	-	-
EPS ²	-85.84	-80.48	-124.5
Distribution rate	-	-	-
Net sales ¹	23	175	212
EBITDA ¹	-518	-514	-997
EBIT ¹	-588	-590	-1,081
Net income ¹	-632	-644	-1,022
Net Debt ¹	-5,582	-4,793	-3,899
Reference price ²	3,695.00	8,310.00	7,010.00
Nbr of stocks (in thousands)	7,882	8,083	8,258
Announcement Date	6/27/24	6/20/25	6/24/26

¹JPY in Million²JPY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
CUORIPS INC.	-	-	-	-	359M
ELI LILLY AND COMPANY	33.19x	12.03x	25.3x	0.59%	1,077B
JOHNSON & JOHNSON	36.75x	6.12x	17.02x	2.15%	612B
ABBVIE INC.	34.92x	8.07x	16.64x	2.53%	501B
MERCK & CO., INC.	109.67x	5.8x	24.85x	2.4%	364B
ROCHE HOLDING AG	19.42x	4.74x	11.78x	2.78%	353B
NOVARTIS AG	20.05x	5.27x	12.97x	3.02%	278B
ASTRAZENECA PLC	20.63x	4.17x	11.97x	2.12%	251B
AMGEN INC.	26.21x	6.79x	12.15x	2.44%	230B
GILEAD SCIENCES, INC.	-43.22x	6.62x	25.76x	2.23%	190B
Average	28.63x	6.62x	17.61x	2.25%	385.69B
Weighted average by Cap.	33.98x	7.74x	19.06x	1.93%